| Literature DB >> 32042027 |
Diego Orcioli-Silva1,2, Fabio Augusto Barbieri3,4, Paulo Cezar Rocha Dos Santos5,3,6, Victor Spiandor Beretta5,3, Lucas Simieli3,4, Rodrigo Vitorio5,3, Ellen Lirani-Silva5,3, Lilian Teresa Bucken Gobbi5,3.
Abstract
Gait asymmetry during unobstructed walking in people with Parkinson's disease (PD) has been well documented. However, under complex situations, such as environments with double obstacles, gait asymmetry remains poorly understood in PD. Therefore, the aim of this study was to analyze inter-limb asymmetry while crossing a single obstacle and double obstacles (with different distances between them) in people with PD and healthy older adults. Nineteen people with PD and 19 healthy older people performed three conditions: (i) walking with one obstacle (Single); (ii) walking with two obstacles with a 50 cm distance between them (Double-50); (iii) walking with two obstacles with a 108 cm distance between them (Double-108). The participants performed the obstacle crossing with both lower limbs. Asymmetry Index was calculated. We found that people with PD presented higher leading and trailing toe clearance asymmetry than healthy older people. In addition, participants increased asymmetry in the Double-50 compared to Single condition. It can be concluded that people with PD show higher asymmetry during obstacle crossing compared to healthy older people, independently of the number of obstacles. In addition, a challenging environment induces asymmetry during obstacle crossing in both people with PD and healthy older people.Entities:
Mesh:
Year: 2020 PMID: 32042027 PMCID: PMC7010667 DOI: 10.1038/s41598-020-59266-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of PD group and control group.
| Demographic measure | PD group | Control group | p-value |
|---|---|---|---|
| Men/women | 10/9 | 10/9 | |
| Age (years) | 71.53 ± 6.39 | 70.37 ± 6.25 | 0.576 |
| Body height (cm) | 161.72 ± 8.13 | 161.04 ± 7.12 | 0.784 |
| Body mass (Kg) | 67.38 ± 9.44 | 72.82 ± 14.86 | 0.187 |
| MMSE (0–30) | 27.50 ± 1.70 | 28.35 ± 1.30 | 0.111 |
| Disease duration (years) | 5.19 ± 3.03 | NA | |
| UPDRS III (0–108) | 27.05 ± 7.60 | NA | |
| Hoehn &Yahr Scale – 1/1.5/2/2.5 | 1/1/9/8 | NA | |
| Most Affected Limb – Right/Left | 4/15 | NA | |
| Levodopa equivalent dose (mg/day) | 585.23 ± 400.24 | NA |
Data are shown as mean ± SD. UPDRS: Unified Parkinson’s Disease Rating Scale; MMSE: Mini-Mental State Examination; NA: not applicable.
Gait characteristics of crossing step for both more affected (MAS) and less affected (LAS) limbs of PD group and both dominant limb (DL) and non-dominant limb (NDL) of control group (CG).
| Gait parameters | Group | Single | Double-50 | Double-108 | |||
|---|---|---|---|---|---|---|---|
| MAS/NDL | LAS/DL | MAS/NDL | LAS/DL | MAS/NDL | LAS/DL | ||
| Step length (cm) | PD | 63.29 ± 7.42 | 62.35 ± 7.59 | 61.58 ± 4.72 | 61.81 ± 3.92 | 61.56 ± 5.80 | 60.35 ± 5.52 |
| CG | 68.54 ± 10.64 | 67.95 ± 8.58 | 64.48 ± 4.74 | 65.05 ± 6.80 | 63.24 ± 5.41 | 63.49 ± 5.40 | |
| Step duration (s) | PD | 0.79 ± 0.12 | 0.78 ± 0.12 | 0.80 ± 0.13 | 0.80 ± 0.12 | 0.78 ± 0.12 | 0.77 ± 0.09 |
| CG | 0.74 ± 0.06 | 0.72 ± 0.08 | 0.75 ± 0.09 | 0.73 ± 0.08 | 0.74 ± 0.08 | 0.73 ± 0.08 | |
| Swing phase (%) | PD | 84.18 ± 2.43 | 83.21 ± 2.07 | 84.47 ± 1.88 | 83.69 ± 2.19 | 83.89 ± 2.18 | 82.89 ± 2.18 |
| CG | 84.39 ± 2.69 | 84.38 ± 2.21 | 84.62 ± 2.55 | 84.09 ± 2.39 | 84.21 ± 2.27 | 83.60 ± 2.62 | |
| Step velocity (cm/s) | PD | 82.77 ± 17.57 | 82.09 ± 16.37 | 78.62 ± 14.56 | 78.86 ± 12.80 | 80.79 ± 14.36 | 79.98 ± 12.76 |
| CG | 94.19 ± 19.66 | 95.46 ± 19.24 | 87.66 ± 15.04 | 91.00 ± 16.32 | 86.09 ± 12.83 | 87.86 ± 14.32 | |
| Leading foot placement (cm) | PD | 73.52 ± 10.90 | 75.55 ± 9.08 | 72.29 ± 8.92 | 74.50 ± 8.11 | 73.38 ± 9.30 | 75.27 ± 8.49 |
| CG | 85.52 ± 16.43 | 85.09 ± 14.42 | 82.35 ± 15.08 | 82.27 ± 15.46 | 82.51 ± 13.27 | 85.08 ± 12.47 | |
| Trailing foot placement (cm) | PD | 22.15 ± 5.25 | 23.79 ± 4.40 | 21.42 ± 3.86 | 22.69 ± 3.51 | 22.22 ± 5.09 | 23.47 ± 4.17 |
| CG | 25.66 ± 7.58 | 25.38 ± 5.88 | 24.35 ± 4.80 | 24.63 ± 5.62 | 25.01 ± 5.41 | 25.45 ± 4.43 | |
| Leading toe clearance (cm) | PD | 14.71 ± 4.38 | 15.11 ± 4.21 | 15.36 ± 3.17 | 15.45 ± 3.66 | 14.04 ± 3.20 | 14.48 ± 3.23 |
| CG | 15.48 ± 1.93 | 16.34 ± 2.17 | 16.16 ± 2.02 | 16.34 ± 2.02 | 15.65 ± 2.74 | 16.29 ± 2.35 | |
| Trailing toe clearance (cm) | PD | 20.90 ± 5.14 | 23.84 ± 6.69 | 21.67 ± 6.08 | 24.39 ± 6.77 | 18.18 ± 4.77 | 20.70 ± 5.32 |
| CG | 22.43 ± 3.23 | 23.71 ± 4.19 | 21.04 ± 2.54 | 22.53 ± 3.44 | 21.31 ± 4.24 | 21.70 ± 3.83 | |
Figure 1Bar graphs of means and standard deviations of Asymmetry Index of crossing step variables. *Represents the main effect of condition with significant differences in post-hoc comparisons between Single vs. Double-50 condition. #Represents the main effect of group.
Figure 2Illustration of the experimental environment. Black feet (upper figure) means the steps considered for analysis. Participants performed three trials for each limb as the leading limb. 1 - Obstacle position in Single condition and Double condition (First obstacle); 2 - Second obstacle positioned at 50 cm from the first obstacle; 3 - Second obstacle positioned at 108 cm from the first obstacle; (a) Trail horizontal distance before obstacle; (b) Lead horizontal distance before obstacle; (c) Toe clearance.